Growth factor and patient-adapted use of plerixafor is superior to CY and growth factor for autologous hematopoietic stem cells mobilization.
| Autor: | Costa, L. J.1 costalj@musc.edu, Miller, A. N.1, Alexander, E. T.1, Hogan, K. R.1, Shabbir, M.1, Schaub, C.1, Stuart, R. K.1 |
|---|---|
| Zdroj: | Bone Marrow Transplantation. Apr2011, Vol. 46 Issue 4, p523-528. 6p. 1 Chart, 3 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|